212 related articles for article (PubMed ID: 22157764)
1. The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation.
Lugassy J; Zaffryar-Eilot S; Soueid S; Mordoviz A; Smith V; Kessler O; Neufeld G
J Biol Chem; 2012 Jan; 287(5):3541-9. PubMed ID: 22157764
[TBL] [Abstract][Full Text] [Related]
2. Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor.
Rodriguez HM; Vaysberg M; Mikels A; McCauley S; Velayo AC; Garcia C; Smith V
J Biol Chem; 2010 Jul; 285(27):20964-74. PubMed ID: 20439985
[TBL] [Abstract][Full Text] [Related]
3. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin.
Kim YM; Kim EC; Kim Y
Mol Biol Rep; 2011 Jan; 38(1):145-9. PubMed ID: 20306300
[TBL] [Abstract][Full Text] [Related]
4. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.
Barry-Hamilton V; Spangler R; Marshall D; McCauley S; Rodriguez HM; Oyasu M; Mikels A; Vaysberg M; Ghermazien H; Wai C; Garcia CA; Velayo AC; Jorgensen B; Biermann D; Tsai D; Green J; Zaffryar-Eilot S; Holzer A; Ogg S; Thai D; Neufeld G; Van Vlasselaer P; Smith V
Nat Med; 2010 Sep; 16(9):1009-17. PubMed ID: 20818376
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
Zaffryar-Eilot S; Marshall D; Voloshin T; Bar-Zion A; Spangler R; Kessler O; Ghermazien H; Brekhman V; Suss-Toby E; Adam D; Shaked Y; Smith V; Neufeld G
Carcinogenesis; 2013 Oct; 34(10):2370-9. PubMed ID: 23828904
[TBL] [Abstract][Full Text] [Related]
6. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells.
Fan Z; Zheng W; Li H; Wu W; Liu X; Sun Z; Hu H; Du L; Jia Q; Liu Q
Oncol Rep; 2020 May; 43(5):1641-1649. PubMed ID: 32323822
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
[TBL] [Abstract][Full Text] [Related]
8. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
9. Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms.
Umana-Diaz C; Pichol-Thievend C; Marchand MF; Atlas Y; Salza R; Malbouyres M; Barret A; Teillon J; Ardidie-Robouant C; Ruggiero F; Monnot C; Girard P; Guilluy C; Ricard-Blum S; Germain S; Muller L
Matrix Biol; 2020 Jun; 88():33-52. PubMed ID: 31759052
[TBL] [Abstract][Full Text] [Related]
10. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
Okada K; Moon HJ; Finney J; Meier A; Mure M
Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
Fujimoto E; Tajima S
J Dermatol Sci; 2009 Aug; 55(2):91-8. PubMed ID: 19394199
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
[TBL] [Abstract][Full Text] [Related]
15. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.
Brekhman V; Lugassie J; Zaffryar-Eilot S; Sabo E; Kessler O; Smith V; Golding H; Neufeld G
FASEB J; 2011 Jan; 25(1):55-65. PubMed ID: 20802105
[TBL] [Abstract][Full Text] [Related]
16. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV
Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888
[TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin.
Schmelzer CEH; Heinz A; Troilo H; Lockhart-Cairns MP; Jowitt TA; Marchand MF; Bidault L; Bignon M; Hedtke T; Barret A; McConnell JC; Sherratt MJ; Germain S; Hulmes DJS; Baldock C; Muller L
FASEB J; 2019 Apr; 33(4):5468-5481. PubMed ID: 30676771
[TBL] [Abstract][Full Text] [Related]
18. LOXL2 from human amniotic mesenchymal stem cells accelerates wound epithelialization by promoting differentiation and migration of keratinocytes.
He D; Zhao F; Jiang H; Kang Y; Song Y; Lin X; Shi P; Zhang T; Pang X
Aging (Albany NY); 2020 Jul; 12(13):12960-12986. PubMed ID: 32621591
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion.
Kamiya T; Kadowaki M; Atobe T; Kunieda K; Morimoto K; Hara H
J Cell Biochem; 2023 Jun; 124(6):797-807. PubMed ID: 37062903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
